- CollPlant Biotechnologies Q1 2026 Earnings Report – MarketBeat
(NASDAQ: CLGN) is a regenerative medicine company that develops and commercializes recombinant human collagen (rhCollagen) and 3D bioprinting … - DePuy Synthes acquires development rights to two advanced medical device technologies
DePuy Synthes also announced an exclusive distribution agreement with CGBIO, a biotechnology company specializing in regenerative medicine, for … - Putin's $26 billion anti-ageing drive blends science and politics – MSN
Future scenarios for Russia's anti-ageing drive. If successful, Russia could position itself as a leader in regenerative medicine, potentially … - Ozone Therapy for Low‐Grade Inflammation – YouTube
… regenerative medicine to help restart and support the body's natural repair processes, from lingering joint injuries and chronic pain to systemic … - Top 9 Nanobiotechnology Companies are Driving Innovation at Nanoscale in 2025
Application of regenerative medicine for tissue repair. Cutting-edge imaging methods with improved precision and resolution. Fortune Business …
